Citigroup and Truist Financial began research coverage and updated ratings for BridgeBio.
1 report, 1 independent
Updated Jul 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup and Truist Financial began research coverage and updated ratings for BridgeBio.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
BridgeBio
company in Palo Alto, United States
Nothing else this week.
-
Citigroup
American investment bank and financial services corporation
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
Related events
- Citigroup boosted its price target and gave a buy rating for Wholesale Club, with MarketBeat providing consensus data.
- Citigroup upgraded its target price and gave a buy rating for Fortrea.
- Truist Financial raised its target price on ArcBest, while Citigroup initiated coverage and Stephens upgraded the stock rating.
- Citigroup restated a buy rating on shares of Intensity Therapeutics.
- Citigroup and Jefferies Financial Group raised their price targets and issued buy ratings for Beauty.